ABBV - AbbVie Inc.
233.86
-0.400 -0.171%
Share volume: 6,548,207
Last Updated: 03-03-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.15%
PREVIOUS CLOSE
CHG
CHG%
$234.26
-0.40
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-03-2024 | 08-07-2024 | 11-04-2024 | 02-14-2025 | 05-09-2025 | 08-04-2025 | 11-04-2025 | 02-20-2026 | |
| Assets | |||||||||
| Total Assets | 148.874 B | 141.937 B | 143.422 B | 135.161 B | 136.165 B | 137.182 B | 133.898 B | 133.960 B | |
| Current Assets | 38.871 B | 33.816 B | 27.785 B | 25.582 B | 27.675 B | 29.261 B | 28.539 B | 29.062 B | |
| Inventories | 4.245 B | 4.218 B | 4.450 B | 4.181 B | 4.526 B | 4.960 B | 4.938 B | 4.951 B | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 2.000 M | 27.000 M | 28.000 M | 31.000 M | 1.000 M | 0.000 | 42.000 M | 28.000 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 18.067 B | 13.130 B | 7.257 B | 5.524 B | 5.175 B | 6.467 B | 5.629 B | 5.229 B | |
| Total Non-current Assets | 305.000 M | 272.000 M | 267.000 M | 279.000 M | 287.000 M | 310.000 M | 291.000 M | 268.000 M | |
| Property Plant Equipment | 4.980 B | 5.023 B | 5.141 B | 5.134 B | 5.237 B | 5.283 B | 5.483 B | 5.628 B | |
| Other Assets | 105.023 B | 103.098 B | 110.496 B | 104.445 B | 103.253 B | 102.638 B | 99.876 B | 99.270 B | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 148.874 B | 141.937 B | 143.422 B | 135.161 B | 136.165 B | 137.182 B | 133.898 B | 133.960 B | |
| Total liabilities | 140.827 B | 135.116 B | 137.351 B | 131.797 B | 134.703 B | 137.320 B | 136.497 B | 137.188 B | |
| Total current liabilities | 41.522 B | 41.915 B | 43.062 B | 38.749 B | 36.403 B | 39.767 B | 39.391 B | 43.289 B | |
| Accounts Payable | 31.326 B | 29.329 B | 30.492 B | 31.945 B | 31.041 B | 32.245 B | 33.619 B | 34.734 B | |
| Other liabilities | 32.778 B | 32.427 B | 33.031 B | 30.129 B | 31.191 B | 32.040 B | 31.655 B | 32.569 B | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 63.805 B | 58.048 B | 58.509 B | 60.340 B | 64.527 B | 62.959 B | 62.971 B | 58.941 B | |
| Other liabilities | 32.778 B | 32.427 B | 33.031 B | 30.129 B | 31.191 B | 32.040 B | 31.655 B | 32.569 B | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 8.007 B | 6.778 B | 6.032 B | 3.325 B | 1.420 B | -183.000 M | -2.642 B | -3.270 B | |
| Common stock | 20.674 B | 20.897 B | 21.178 B | 21.351 B | 21.826 B | 22.005 B | 22.309 B | 22.513 B | |
| Retained earnings | -2.384 B | -3.768 B | -4.964 B | -7.900 B | -9.527 B | -11.503 B | -14.234 B | -15.493 B |